Chemical Component Summary

NamePAMIDRONATE
Identifiers(3-amino-1-hydroxy-1-phosphono-propyl)phosphonic acid
FormulaC3 H11 N O7 P2
Molecular Weight235.07
TypeNON-POLYMER
Isomeric SMILESNCCC(O)([P](O)(O)=O)[P](O)(O)=O
InChIInChI=1S/C3H11NO7P2/c4-2-1-3(5,12(6,7)8)13(9,10)11/h5H,1-2,4H2,(H2,6,7,8)(H2,9,10,11)
InChIKeyWRUUGTRCQOWXEG-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count24
Chiral Atom Count0
Bond Count23
Aromatic Bond Count0

Drug Info: DrugBank

DrugBank IDDB00282 
NamePamidronic acid
Groupsapproved
DescriptionPamidronic acid is a second generation, nitrogen containing bisphosphonate similar to [neridronic acid] and [alendronic acid].[A203111] Pamidronic acid was first described in the literature in 1977.[A203267] The second generation bisphosphonates are less common as third generation bisphosphonates, such as [ibandronic acid], [zoledronic acid], [minodronic acid], and [risedronic acid] are becoming more popular.[A203111] Pamidronic acid was granted FDA approval on 31 October 1991.[L13835]
Synonyms
  • Acido pamidronico
  • Pamidronate Disodium
  • Acidum pamidronicum
  • Pamidronic acid
  • Pamidronate
Brand Names
  • Val-pamidronate Disodium
  • Pamidronate Disodium Omega 3 mg/ml
  • Pamidronate Disodium for Injection
  • Pamidronate Disodium
  • Pamidronate Disodium Omega 9 mg/ml
IndicationPamidronate is indicated to treat moderate to severe hypercalcemia of malignancy, moderate to severe Paget's disease of bone, osteolytic bone metastases of breast cancer, and osteolytic lesions of multiple myeloma.[L13838]
Categories
  • Agents Causing Muscle Toxicity
  • Antineoplastic Agents
  • Bisphosphonates
  • Bone Density Conservation Agents
  • Drugs Affecting Bone Structure and Mineralization
ATC-CodeM05BA03
CAS number40391-99-9

Drug Targets

NameTarget SequencePharmacological ActionActions
Farnesyl pyrophosphate synthaseMPLSRWLRSVGVFLLPAPYWAPRERWLGSLRRPSLVHGYPVLAWHSARCW...unknowninhibitor
Hydroxylapatite-unknownantagonist
Geranylgeranyl pyrophosphate synthaseMEKTQETVQRILLEPYKYLLQLPGKQVRTKLSQAFNHWLKVPEDKLQIII...unknowninhibitor
Caspase-3MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIII...unknowncleavage
Caspase-9MDEADRRLLRRCRLRLVEELQVDQLWDALLSRELFRPHMIEDIQRAGSGS...unknowncleavage
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682